(Q45072400)

9 December 2017

title

Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer (English)

1 reference

9 December 2017

1 reference

Michael Hubalek

1

1 reference

9 December 2017

Angela Ramoni

series ordinal

2

1 reference

9 December 2017

Elisabeth Mueller-Holzner

series ordinal

3

1 reference

9 December 2017

Christian Marth

series ordinal

4

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

9 December 2017

1 reference

9 December 2017

volume

95

1 reference

9 December 2017

issue

1

1 reference

9 December 2017

page(s)

264-266

1 reference

Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.039

Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.039

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.039

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.039

Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.039

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.039

10.1016/J.YGYNO.2004.06.039

7 January 2021

Identifiers

DOI

1 reference

9 December 2017

1 reference